Union Korea Pharm Co., Ltd. has completed an IPO in the amount of KRW 27 billion.
July 23, 2018 at 09:30 am IST
Share
Union Korea Pharm Co., Ltd. has completed an IPO in the amount of KRW 27 billion.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 1,500,000
PriceRange: KRW 18000
Discount Per Security: KRW 720
UNION KOREA PHARM CO.LTD. is a Korea-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Company manufactures and sells specialty medicines through formulations such as solid dosage forms, liquid injections, and cefa powder injections. Major products include antibiotics such as kepodon injection and ceftazime injection 1g for the prevention and treatment of infectious diseases; musculoskeletal drugs for treating arthritis contains unihyal injection and galithio injection; circulatory system dugs for the treatment of cerebrovascular diseases, such as cacetile tab and limasta tab; as well as drugs for digestive system such as digestive disorders. In addition, the Company engaged in the contract manufacturing operation (CMO) business for other pharmaceutical companies. The Company distributes its products within domestic market and to overseas markets including Middle East, Southeast Asia and Latin America.
UNION KOREA PHARM CO., LTD. 
